Beta 3 agonists. Part 1: evolution from inception to BMS-194449
- 5 October 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (23) , 3035-3039
- https://doi.org/10.1016/s0960-894x(01)00628-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Development of ?3-adrenoceptor agonists as antiobesity and antidiabetes drugs in humans: Current status and future prospectsDrug Development Research, 2000
- Obesity in the new millenniumNature, 2000
- Towards a molecular understanding of adaptive thermogenesisNature, 2000
- Medicinal strategies in the treatment of obesityNature, 2000
- Pharmacological Treatment of Obesity: Therapeutic StrategiesJournal of Medicinal Chemistry, 1999
- β3 Adrenergic Receptor Agonists for the Treatment of ObesityPublished by Elsevier ,1998
- The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010Diabetic Medicine, 1997
- CL 316,243Drugs of the Future, 1994
- BRL 35135Drugs of the Future, 1991
- Molecular Characterization of the Human β 3 -Adrenergic ReceptorScience, 1989